SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $276 | -98.6% | 2 | -98.7% | 0.00% | -100.0% |
| Q4 2022 | $19,826 | +147.8% | 153 | +57.7% | 0.00% | +200.0% |
| Q1 2022 | $8,000 | -11.1% | 97 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | 0.0% | 97 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | +28.6% | 97 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | – | 95 | +2275.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 4 | -96.2% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | +20.0% | 104 | 0.0% | 0.01% | +33.3% |
| Q3 2020 | $15,000 | -11.8% | 104 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $17,000 | +70.0% | 104 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $10,000 | -23.1% | 104 | +4.0% | 0.01% | 0.0% |
| Q4 2019 | $13,000 | – | 100 | +3233.3% | 0.01% | – |
| Q1 2019 | $0 | -100.0% | 3 | -72.7% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |